Primary Aldosteronism
105
39
42
38
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 105 trials
100.0%
+13.5% vs benchmark
10%
10 trials in Phase 3/4
8%
3 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (105)
Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism
Steroids-Based Screening for Primary Aldosteronism
Study of QLS1410 in the Treatment of Primary Aldosteronism.
REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study
A Study of CIN-107 in Adults With Primary Aldosteronism
Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA
Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)
Prognosis of Primary Aldosteronism: A Prospective Cohort Study
Genetic Predisposition to High Blood Pressure
The Association Between Primary Aldosteronism and Cognitive Dysfunction
Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE)
The Effect of SAAE on Vascular Endothelial Function in PA Patients
Multi-omics Studies of Primary Aldosteronism
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
Overnight Dexamethasone in Primary Aldosteronism Screening
Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism